AEON Biopharma, Inc. 4
4 · Evolus, Inc. · Filed Jan 10, 2020
Insider Transaction Report
Form 4
Evolus, Inc.EOLS
Alphaeon Corp
10% Owner
Transactions
- Other
Common Stock
2020-01-08−8,662,346→ 0 total
Footnotes (1)
- [F1]Pursuant to a Contribution Agreement dated January 8, 2020, by and between the Reporting Person (formerly known as Alphaeon Corporation) and Alphaeon 1 LLC ("Alphaeon"), on January 8, 2020, the Reporting Person contributed 8,662,346 shares of the Issuer to Alphaeon (the "Contribution"). The shares of the Issuer contributed to Alphaeon are deemed "restricted securities" under Rule 144 promulgated under the Securities Act of 1933, as amended. At the time of the Contribution, Alphaeon was a wholly-owned subsidiary of the Reporting Person. Immediately after the Contribution, the Reporting Person distributed out all of the membership interests of Alphaeon to its stockholders. The Reporting Person is filing this exit Form 4 to report that it is no longer a beneficial owner of the Issuer's securities.